Home › Bids
› Digital Health Technology Derived Biomarkers and Outcome Ass
Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)
This bid is closed — responses were due June 22, 2026.
It is no longer accepting submissions. We keep closed bids on BidsNexus for reference: agencies often re-issue the same need, and past bids show what they buy and when.
This grant opportunity (PAR-25-170) from NIH supports research into digital health technology derived biomarkers and outcome assessments for remote monitoring and endpoint development. It utilizes a UG3/UH3 phased award mechanism and is clinical trial optional, aiming to advance the use of digital health technologies in clinical research.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
Digital Health Technology Development Services
1
lot
$1,000,000.00
$1,000,000.00
IT Services
Biomarker Development Services
1
lot
$500,000.00
$500,000.00
Professional Services
Outcome Assessment Development Services
1
lot
$500,000.00
$500,000.00
Professional Services
Remote Monitoring Technology
1
lot
$500,000.00
$500,000.00
IT Hardware
Data Analysis Software
1
lot
$500,000.00
$500,000.00
IT Software
Clinical Trial (Optional)
1
lot
$2,000,000.00
$2,000,000.00
Medical
Estimated Bid Value
$5,000,000.00
Want the full details?
Sign up free to see the agency name and the original bid posting link. Pro adds contracting-officer contacts and AI response outlines.